The first stop for professional medicines advice

Apixaban

7 results

Applied filters

Managing interactions with direct oral anticoagulants (DOACs)

5 January 2024Interactions with apixaban, dabigatran, edoxaban or rivaroxaban can result in increased risks of a bleed or thrombosis. We advise on management options.

Understanding direct oral anticoagulant (DOAC) interactions

5 January 2024It is important to understand the risks, mechanisms of interactions and actions to take when prescribing medicines with DOACs.

Using intramuscular injections in people on oral anticoagulants

20 September 2023Advice on risks related to use of small volume (less than 3mL) intramuscular (IM) injections in people on oral anticoagulants (for example, DOACs, warfarin)

Accessing resources for patients on high risk medicines

19 December 2022A number of resources are available to support the safe use of high-risk medicines. Healthcare professionals should ensure they are available for their patients

Using oral anticoagulants during breastfeeding

2 November 2021Warfarin is the preferred choice during breastfeeding; rivaroxaban or dabigatran may also be used. Recommendations apply to full term and healthy infants.

DOACs (Direct Oral Anticoagulants) monitoring

5 July 2021

Anticoagulant suggestions for adults with swallowing difficulties

1 July 2021A range of oral anticoagulant formulations are suitable for adults with swallowing difficulties.
OSZAR »